Effectiveness Verification of a Smartphone-based System for Assessment and Health Care on Myofascial Pain Syndrome
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
Myofascial pain syndrome (MPS) is the most common musculoskeletal pain disorder. The pain originates from myofascial trigger points (TrPs) in skeletal muscle. The muscle that presents with TrPs would be identified through clinical diagnosis and assessment, and further treatment would be designed according to the identified muscle.With the high penetration rate of smartphones, it would be convenient to utilize smartphones as the assistive technology in the assessment and intervention of MPS. The smartphone-based MPS assessment and care system could eliminate the restrictions of the epidemic, and provide an independent usage, precisely identifying muscle with TrPs and personalized care plan application. Therefore, the purpose of this study is to 1. develop a smartphone-based assessment and health care system for patients with myofascial pain syndrome. And to 2. verify the feasibility and validity of the system assessment function. And to 3. testify the effectiveness of the system health care functions for patient intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 18, 2024
CompletedFirst Posted
Study publicly available on registry
April 23, 2024
CompletedStudy Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedApril 24, 2024
April 1, 2024
1 month
April 18, 2024
April 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
current pain visual analogue scale
pain will be evaluated with visual analogue scale(VAS). 0 means no pain at all;10 means extremely painful.
10 minutes
Secondary Outcomes (1)
functional questionnaire
20 minutes
Study Arms (2)
App group
EXPERIMENTALControl group
ACTIVE COMPARATORInterventions
Self-developed app: includes home stretching and strengthening exercises, muscle release technique instruction.
Eligibility Criteria
You may qualify if:
- For those diagnosed with myofascial pain syndrome by a rehabilitation physician, the diagnostic conditions meet the five major signs, including:
- Regional pain,
- Transfer pain,
- Muscle tight band,
- Tender points in the tight band. ,
- Limitation of joint mobility,
- And symptoms consistent with any of the items, including:
- Complaints of pain that appear after applying pressure on tender points,
- Local throbbing reaction,
- Pain disappears after injection or after stretching
You may not qualify if:
- Have any neurological diseases that may cause pain,
- have a history of surgery in the past six months,
- the affected area is in a state of acute inflammation,
- have open wounds, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- China Medical University Hospitallead
- National Cheng Kung Universitycollaborator
- National Science and Technology Councilcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
April 18, 2024
First Posted
April 23, 2024
Study Start
May 1, 2024
Primary Completion
June 1, 2024
Study Completion
December 1, 2024
Last Updated
April 24, 2024
Record last verified: 2024-04